Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2014

Open Access 01-12-2014 | Research article

The effects of vitamin C supplementation on pre-eclampsia in Mulago Hospital, Kampala, Uganda: a randomized placebo controlled clinical trial

Authors: Paul Kiondo, Gakenia Wamuyu-Maina, Julius Wandabwa, Gabriel S Bimenya, Nazarius Mbona Tumwesigye, Pius Okong

Published in: BMC Pregnancy and Childbirth | Issue 1/2014

Login to get access

Abstract

Background

Oxidative stress plays a role in the pathogenesis of pre-eclampsia. Supplementing women with antioxidants during pregnancy may reduce oxidative stress and thereby prevent or delay the onset pre-eclampsia. The objective of this study was to evaluate the effect of supplementing vitamin C in pregnancy on the incidence of pre-eclampsia, at Mulago hospital, Kampala, Uganda.

Methods

This was a (parallel, balanced randomization, 1:1) placebo randomized controlled trial conducted at Mulago hospital, Department of Obstetrics and Gynecology. Participants included in this study were pregnant women aged 15-42 years, who lived 15 km or less from the hospital with gestational ages between 12-22 weeks. The women were randomized to take 1000mg of vitamin C (as ascorbic acid) or a placebo daily until they delivered. The primary outcome was pre-eclamsia. Secondary outcomes were: severe pre-eclampsia, gestational hypertension, preterm delivery, low birth weight and still birth delivery. Participants were 932 pregnant women randomized into one of the two treatment arms in a ratio of 1:1. The participants, the care providers and those assessing the outcomes were blinded to the study allocation.

Results

Of the 932 women recruited; 466 were randomized to the vitamin and 466 to the placebo group. Recruitment of participants was from November 2011 to June 2012 and follow up was up to January 2013. Outcome data was available 415 women in the vitamin group and 418 women in the placebo group.
There were no differences in vitamin and placebo groups in the incidence of pre-eclampsia (3.1% versus 4.1%; RR 0.77; 95% CI: 0.37-1.56), severe pre-eclampsia (1.2% versus 1.0%; RR 1.25; 95% CI: 0.34-4.65), gestational hypertension(7.7% versus 11.5%; RR 0.67; 95% CI: 0.43-1.03), preterm delivery (11.3% versus 12.2%; RR 0.92; 95% CI: 0.63-1.34), low birth weight (11.1% versus 10.3%; RR 1.07; 95% CI: 0.72-1.59) and still birth delivery (4.6% versus 4.5%; RR 1.01; 95% CI: 0.54-1.87).

Conclusions

Supplementation with vitamin C did not reduce the incidence of pre-eclampsia nor did it reduce the adverse maternal or neonatal outcomes. We do not recommend the use of vitamin C in pregnancy to prevent pre-eclampsia.

Trial registration

This study was registered at the Pan African Clinical Trial Registry, PACTR201210000418271 on 25th October 2012.
Appendix
Available only for authorised users
Literature
1.
Duley L: Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992, 99 (7): 547-553.CrossRefPubMed
2.
Hogberg U: The World Health Report 2005: “make every mother and child count” - including Africans. Scand J Public Health. 2005, 33 (6): 409-411.CrossRefPubMed
3.
Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y: Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol. 2000, 156 (1): 321-331.CrossRefPubMedPubMedCentral
4.
ACOG Committee on Practice Bulletins-Obstetrics: ACOG practice bulletin: diagnosis and management of pre-eclampsia and eclampsia: number 33, January 2002. Obstet Gynecol. 2002, 99: 159-167.CrossRef
5.
Onah HE, Okaro JM, Umeh U, Chigbu CO: Maternal mortality in health institutions with emergency obstetric care facilities in Enugu State, Nigeria. J Obstet Gynaecol. 2005, 25 (6): 569-574.CrossRefPubMed
6.
Sibai BM: Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003, 102 (1): 181-192.PubMed
7.
Wandabwa JN, Doyle P, Longo-Mbenza B, Kiondo P, Khainza B, Othieno E, Maconichie N: Human immunodeficiency virus and AIDS and other important predictors of maternal mortality in Mulago Hospital Complex Kampala Uganda. BMC Public Health. 2011, 11: 565-CrossRefPubMedPubMedCentral
8.
Haddad B, Deis S, Goffinet F, Paniel BJ, Cabrol D, Siba BM: Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks” gestation. Am J Obstet Gynecol. 2004, 190 (6): 1590-1595. discussion 1595-1597CrossRefPubMed
9.
Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G, Miodovnik M, Meis P, Thurnau G: Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002, 186 (1): 66-71.CrossRefPubMed
10.
Ong KK: Catch-up growth in small for gestational age babies: good or bad?. Curr Opin Endocrinol Diabetes Obes. 2007, 14 (1): 30-34.CrossRefPubMed
11.
Dudell GG, Jain L: Hypoxic respiratory failure in the late preterm infant. Clin Perinatol. 2006, 33 (4): 803-830.CrossRefPubMed
12.
Agarwal A, Gupta S, Sharma R: Oxidative stress and its implications in female infertility - a clinician’s perspective. Reprod Biomed Online. 2005, 11 (5): 641-650.CrossRefPubMed
13.
Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science (New York, NY). 2005, 308 (5728): 1592-1594.CrossRef
14.
Poston L, Raijmakers MT: Trophoblast oxidative stress, antioxidants and pregnancy outcome--a review. Placenta. 2004, 25 (Suppl A): S72-S78.CrossRefPubMed
15.
Hubel CA: Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999, 222 (3): 222-235.CrossRefPubMed
16.
Kiondo P, Tumwesigye NM, Wandabwa J, Wamuyu-Maina G, Bimenya GS, Okong P: Plasma vitamin C assay in women of reproductive age in Kampala, Uganda using a colorimetric method. Trop Med Int Health. 2012, 17 (2): 191-196.CrossRefPubMed
17.
Roberts JM, Hubel CA: Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet. 1999, 354 (9181): 788-789.CrossRefPubMed
18.
19.
Hiby SE, Walker JJ, O’Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exper Med. 2004, 200 (8): 957-965.CrossRef
20.
Roberts JM, Cooper DW: Pathogenesis and genetics of pre-eclampsia. Lancet. 2001, 357 (9249): 53-56.CrossRefPubMed
21.
Bodnar LM, Tang G, Ness RB, Harger G, Roberts JM: Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol. 2006, 164 (5): 470-477.CrossRefPubMed
22.
Klemmensen A, Tabor A, Osterdal ML, Knudsen VK, Halldorsson TI, Mikkelsen TB, Olsen SF: Intake of vitamin C and E in pregnancy and risk of pre-eclampsia: prospective study among 57 346 women. BJOG. 2009, 116 (7): 964-974.CrossRefPubMed
23.
Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, Mallet A, Poston L: Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol. 2002, 187 (3): 777-784.CrossRefPubMed
24.
Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L: Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1999, 354 (9181): 810-816.CrossRefPubMed
25.
Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM: Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol. 2005, 192 (2): 520-521.CrossRefPubMed
26.
Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS: Vitamins C and E and the risks of preeclampsia and perinatal complications. N Eng J Med. 2006, 354 (17): 1796-1806.CrossRef
27.
Villar J, Purwar M, Merialdi M, Zavaleta N, Thi Nhu Ngoc N, Anthony J, De Greeff A, Poston L, Shennan A: World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG. 2009, 116 (6): 780-788.CrossRefPubMed
28.
Kiondo P, Wamuyu-Maina G, Bimenya GS, Tumwesigye NM, Wandabwa J, Okong P: Risk factors for pre-eclampsia in Mulago Hospital, Kampala, Uganda. Trop Med Int Health. 2012, 17 (4): 480-487.CrossRefPubMed
29.
Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001, 20 (1): 9-14.CrossRef
30.
ACOG Practice Bulletin: Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002, 77: 67-75.CrossRef
31.
Hung TH, Burton GJ: Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol. 2006, 45 (3): 189-200.CrossRefPubMed
32.
33.
Kaye D, Mirembe F, Aziga F, Namulema B: Maternal mortality and associated near-misses among emergency intrapartum obstetric referrals in Mulago Hospital, Kampala, Uganda. East Afr Med J. 2003, 80 (3): 144-149.PubMed
34.
Hospital M: Department of Obstetrics and Gynaecolgy Annual Reports. 2010
35.
36.
Zhang C, Williams MA, King IB, Dashow EE, Sorensen TK, Frederick IO, Thompson ML, Luthy DA: Vitamin C and the risk of preeclampsia--results from dietary questionnaire and plasma assay. Epidemiology. 2002, 13 (4): 409-416.CrossRefPubMed
37.
Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH: Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006, 367 (9517): 1145-1154.CrossRefPubMed
38.
Roberts JM, Speer P: Antioxidant therapy to prevent preeclampsia. Semin Nephrol. 2004, 24 (6): 557-564.CrossRefPubMed
39.
Mignini LE, Latthe PM, Villar J, Kilby MD, Carroli G, Khan KS: Mapping the theories of preeclampsia: the role of homocysteine. Obstet Gynecol. 2005, 105 (2): 411-425.CrossRefPubMed
40.
Kiondo P, Tumwesigye NM, Wandabwa J, Wamuyu-Maina G, Bimenya GS, Okong P: Plasma vitamin C assay in women of reproductive age in Kampala, Uganda, using a colorimetric method. 2011, TM & IH: Tropical medicine & international health
41.
Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, Chen S, Corpe C, Dutta A, Dutta SK, Levine M: Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003, 22 (1): 18-35.CrossRefPubMed
42.
Spinnato JA, Freire S, Pinto ESJL, Cunha Rudge MV, Martins-Costa S, Koch MA, Goco N, Santos Cde B, Cecatti JG, Costa R, Ramos JG, Moss N, Sibai BM: Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol. 2007, 110 (6): 1311-1318.CrossRefPubMed
43.
Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, Pearson GD, Wapner RJ, Varner MW, Thorp JM, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Harper M, Smith WJ, Saade G, Sorokin Y, Anderson GB, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Harper M, Smith WJ, Saade G, et al: Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010, 362 (14): 1282-1291.CrossRefPubMedPubMedCentral
44.
Carr A, Frei B: Does vitamin C act as a pro-oxidant under physiological conditions?. FASEB J. 1999, 13 (9): 1007-1024.PubMed
45.
Rietjens IM, Boersma MG, Haan L, Spenkelink B, Awad HM, Cnubben NH, van Zanden JJ, Woude H, Alink GM, Koeman JH: The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ Toxicol Pharmacol. 2002, 11 (3–4): 321-333.CrossRefPubMed
46.
Steyn PS, Odendaal HJ, Schoeman J, Stander C, Fanie N, Grove D: A randomised, double-blind placebo-controlled trial of ascorbic acid supplementation for the prevention of preterm labour. J Obstet Gynaecol. 2003, 23 (2): 150-155.CrossRefPubMed
Metadata
Title
The effects of vitamin C supplementation on pre-eclampsia in Mulago Hospital, Kampala, Uganda: a randomized placebo controlled clinical trial
Authors
Paul Kiondo
Gakenia Wamuyu-Maina
Julius Wandabwa
Gabriel S Bimenya
Nazarius Mbona Tumwesigye
Pius Okong
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2014
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/1471-2393-14-283

Other articles of this Issue 1/2014

BMC Pregnancy and Childbirth 1/2014 Go to the issue

Research article

A qualitative descriptive study of the group prenatal care experience: perceptions of women with low-risk pregnancies and their midwives

Research article

Accessibility and potency of uterotonic drugs purchased by simulated clients in four districts in India

Research article

Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American population

Research article

The association between timing of initiation of antenatal care and stillbirths: a retrospective cohort study of pregnant women in Cape Town, South Africa

Research article

Determinants of unintended pregnancies in rural Ghana

Study protocol

WHO multicentre study for the development of growth standards from fetal life to childhood: the fetal component